H
Harvest
Tax-loss replacement research
REGN
Regeneron Pharmaceuticals
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for REGN

Among the 28 Biotechnology peers screened, AMGN (Amgen Inc.) has tracked REGN most closely over the past year, with a return correlation of 0.48. The strongest fund stand-in is IBB (iShares Biotechnology ETF) at 0.55 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
AMGNAmgen Inc.Biotechnology0.480.410.390.44
VRTXVertex PharmaceuticalsBiotechnology0.370.350.380.46
BIIBBiogen Inc.Biotechnology0.340.420.360.35
BMRNBioMarin PharmaceuticalBiotechnology0.330.340.330.37
GILDGilead SciencesBiotechnology0.320.330.350.41
INCYIncyteBiotechnology0.310.350.360.41
EXELExelixisBiotechnology0.310.240.230.33
HALOHalozymeBiotechnology0.280.220.230.30
PTGXProtagonist Therapeutics, Inc.Biotechnology0.250.250.170.13
SRPTSarepta TherapeuticsBiotechnology0.250.240.220.24
ROIVRoivant SciencesBiotechnology0.240.280.18
XNCRXencor IncBiotechnology0.230.270.260.30
TGTXTG Therapeutics, Inc.Biotechnology0.230.170.160.20
RCUSArcus Biosciences, Inc.Biotechnology0.230.290.240.25
NBIXNeurocrine BiosciencesBiotechnology0.220.250.270.31
KRYSKrystal BiotechBiotechnology0.220.260.200.19
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.210.210.230.31
VIRVir Biotechnology, Inc.Biotechnology0.210.240.230.17
VCELVericelBiotechnology0.210.210.200.18
MRNAModerna Inc.Biotechnology0.200.210.240.23
ADMAADMA Biologics, Inc.Biotechnology0.190.210.210.15
UTHRUnited TherapeuticsBiotechnology0.190.240.260.32
RGENRepligenBiotechnology0.180.250.270.30
FTREFortreaBiotechnology0.160.200.19
CYTKCytokineticsBiotechnology0.120.180.190.22
ALNYAlnylam PharmaceuticalsBiotechnology0.110.200.230.31
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.110.150.19
ARWRArrowhead PharmaceuticalsBiotechnology0.110.240.260.22
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.550.590.570.62
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.500.520.520.53
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.500.520.520.53
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.490.510.510.53
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.480.510.510.52
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.460.480.460.49
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.460.480.460.51
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.420.460.410.48
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.370.430.410.46
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.290.310.350.39
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.230.300.300.36
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.180.220.280.33
NEXT STEPS

Harvesting a loss in REGN?

RELATED

Replacement research for REGN's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.